155 related articles for article (PubMed ID: 11932138)
1. Comparative in-vitro activity of penicillin alone and combined with gentamicin against clinical isolates of Streptococcus pneumoniae with decreased susceptibility to penicillin.
Anadiotis L; Maskell JP; Sefton AM
Int J Antimicrob Agents; 2002 Mar; 19(3):173-81. PubMed ID: 11932138
[TBL] [Abstract][Full Text] [Related]
2. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
4. Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance.
Djurkovic S; Loeffler JM; Fischetti VA
Antimicrob Agents Chemother; 2005 Mar; 49(3):1225-8. PubMed ID: 15728935
[TBL] [Abstract][Full Text] [Related]
5. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae.
Friedland IR; Paris M; Shelton S; McCracken GH
J Antimicrob Chemother; 1994 Aug; 34(2):231-7. PubMed ID: 7814283
[TBL] [Abstract][Full Text] [Related]
6. Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.
Cercenado E; Díaz MD; Sánchez-Carrillo C; Vicente T; Bernaldo de Quirós JC
Antimicrob Agents Chemother; 1995 Dec; 39(12):2816-8. PubMed ID: 8593029
[TBL] [Abstract][Full Text] [Related]
7. Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro.
Lin E; Stanek RJ; Mufson MA
Antimicrob Agents Chemother; 2003 Mar; 47(3):1151-3. PubMed ID: 12604560
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci.
Gross ME; Giron KP; Septimus JD; Mason EO; Musher DM
Antimicrob Agents Chemother; 1995 May; 39(5):1166-8. PubMed ID: 7625807
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of gentamicin as an adjunct to penicillin against biofilm group B Streptococcus.
Ruppen C; Hemphill A; Sendi P
J Antimicrob Chemother; 2017 Feb; 72(2):444-447. PubMed ID: 27999071
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of gentamycin combined with beta-lactam antibiotics against penicillin-resistant and non-resistant Streptococcus agalactiae].
Villar H; Jugo M; Farinati A
Enferm Infecc Microbiol Clin; 1994 Oct; 12(8):385-9. PubMed ID: 7981289
[TBL] [Abstract][Full Text] [Related]
11. The in-vitro activity of combinations of penicillin and gentamicin against penicillin-resistant and penicillin-sensitive Streptococcus pneumoniae.
Haynes J; Hawkey PM; Williams EW
J Antimicrob Chemother; 1986 Sep; 18(3):426-8. PubMed ID: 3771429
[No Abstract] [Full Text] [Related]
12. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
Desbiolles N; Piroth L; Lequeu C; Neuwirth C; Portier H; Chavanet P
Antimicrob Agents Chemother; 2001 Dec; 45(12):3328-33. PubMed ID: 11709304
[TBL] [Abstract][Full Text] [Related]
13. In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococci.
Schlegel L; Sissia G; Fremaux A; Geslin P
J Antimicrob Chemother; 1997 Jan; 39(1):95-8. PubMed ID: 9044034
[TBL] [Abstract][Full Text] [Related]
14. Interaction between beta-lactam antibiotics and gentamicin against Streptococcus pneumoniae in vitro and in vivo.
Frimodt-Møller N; Frølund Thomsen V
Acta Pathol Microbiol Immunol Scand B; 1987 Oct; 95(5):269-75. PubMed ID: 3673584
[TBL] [Abstract][Full Text] [Related]
15. Effects of combination of benzylpenicillin and fosfomycin on penicillin-resistant Streptococcus pneumoniae.
Kikuchi K; Totsuka K; Shimizu K; Ishii T; Yoshida T; Orikasa Y
Microb Drug Resist; 1995; 1(2):185-9. PubMed ID: 9158754
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics.
Marchese A; Debbia EA; Arvigo A; Pesce A; Schito GC
J Antimicrob Chemother; 1995 Nov; 36(5):833-7. PubMed ID: 8626265
[TBL] [Abstract][Full Text] [Related]
17. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
Bañón Arias R; García López M; Pinedo Sánchez A
J Chemother; 2001 Oct; 13(5):535-40. PubMed ID: 11760218
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antibiotic combinations against penicillin-resistant pneumococci.
Cassinat B; Nicolas MH
J Antimicrob Chemother; 1994 Nov; 34(5):785-90. PubMed ID: 7706174
[TBL] [Abstract][Full Text] [Related]
19. Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniae.
Jones RN; Johnson DM
Diagn Microbiol Infect Dis; 1998 Jun; 31(2):373-6. PubMed ID: 9635912
[TBL] [Abstract][Full Text] [Related]
20. Antistreptococcal activity of Sch 34343, a new penem antibiotic.
Yu PK; Washington JA
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():67-71. PubMed ID: 3928578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
